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ABSTRACT
Smoking has addictive implication primarily due to tobacco. 
This addiction usually starts in the early teenage years and 
because of which many manifestations are seen. Nicotine has 
pervasive effects on brain, difficulty in cognitive processing and 
so many effects. Combination of the 4,000 or more chemical 
components of tobacco smoke, including a huge arsenal of 
toxins and carcinogens, represent the mediators of multiple 
pathogenic processes. Nicotine has various delivery systems 
like cigarette, cigar and pipe and smokeless tobacco. At the 
time of quitting tobacco individual faces many withdrawal 
symptoms due to craving. These withdrawal symptoms 
particularly irritability, restlessness, feeling miserable, impaired 
concentration, and increased appetite begin within hours of the 
last cigarette and are at maximal intensity for the first week. But 
social influences greatly influence addiction patterns. These 
can be used to discourage smoking. Successful interventions 
need to tackle the interacting constellation of factors—personal, 
family; socioeconomic, and pharmacological.
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INTRODUCTION
For a very long time smoking was regarded as a socially 
acquired habit. However, now the role of nicotine in sus-
taining smoking behavior has come in picture.1 Cigarette 
smoking is mainly a manifestation of nicotine addiction. 
Various other factors like social, economic, personal, and 
political influences play an important part in determining 
patterns of smoking prevalence and cessation. Of these 
the critical factors are family and wider social influences 
are which are instrumental in determining who starts 
smoking, who gives up, and who continues.
WHY DO PEOPLE START SMOKING?
Smoking usually occurs in the early teenage years and is 
driven predominantly by peer pressure and psychosocial 
motives. For a beginner, smoking a cigarette is a symbolic 
act conveying messages “such as Philip Morris,” I am no 
longer my mother’s child, and I am tough. 
Teenagers who indulge in it tend to come from 
backgrounds that favor smoking (e.g., with high 
levels of smoking in parents, siblings, and peers; rela-
tively deprived neighborhoods; schools where smoking 
is common). There is a psychological feeling in them of 
not to be succeeding according to their own or society’s 
terms (e.g., they have low self-esteem, have impaired 
psychological well-being, are overweight, or are poor 
achievers at school).
Again as quoted by Philip Morris, “as the force from the 
psychosocial symbolism subsides, the pharmacological 
effect takes over to sustain the habit.”
Consequences of Nicotine on Human Body2
Nicotine is quickly absorbed from the lung and almost 
completely. Nicotine reaches the brain faster than intrave-
nous injection which is just within 10 to 16 seconds. The 
half life of nicotine is 15 to 20 minutes which is why regu-
lar cigarettes are needed due to the high blood nicotine 
blood concentrations from each cigarette and overnight 
blood levels dropping to close to those of non-smokers.
Nicotine has pervasive effects on brain. It induces 
the release of dopamine. This effect is the thought to 
be a critical feature of brain addiction mechanisms. In 
new users nicotine improves performance on tasks of 
sustained attention.
However, chronic users probably do not continue to 
obtain absolute improvements in performance, cognitive 
processing, or mood as tolerance to many of these effects 
soon develops. It is reported by smokers that cigarettes 
aid as stress busters and help them to concentrate and 
work more effectively.
The reason why smokers perceive cigarettes to be 
relieving is because smokers start to experience impair-
ment of mood and performance within hours of their last 
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cigarette, and these symptoms are completely subsided 
by smoking a cigarette. Smokers go through this process 
thousands of times over the course of their smoking 
career, and this may lead them to identify cigarettes as 
effective self-medication, even if the effect is the nega-
tive one of withdrawal relief rather than any absolute 
improvement.2
Both smoked and smokeless forms of tobacco contain 
nicotine3, a highly addictive chemical, making it difficult 
for habituated tobacco users to quit.4,5
In fact, it is as addictive, or even more, than heroin or 
cocaine. Over time, users become dependent on nicotine 
and suddenly stopping produces both physical and psy-
chological withdrawal symptoms.6,7 Nicotine is readily 
absorbed from the respiratory tract, buccal mucosa and 
skin.8 
There is minimal absorption through the gastro-
intestinal tract when administered orally. Cigarettes 
are highly effective mechanism for delivering nicotine. 
Inhaled nicotine takes about 10 to 19 seconds to reach the 
brain and its stimulation releases chemicals which ensure 
feeling of goodness, alertness and energy.
As the person stops tobacco use, these chemicals dec-
rease in the body and withdrawal symptoms start. These 
can be very distressing for the unprepared tobacco user. 
Thus, the tobacco user is compelled to continue using 
tobacco, hence trapped in the vicious cycle.
PATHOGENIC EFFECTS OF NICOTINE
Some combination of the 4,000 or more chemical 
components of tobacco smoke, including a huge arsenal 
of toxins and carcinogens, represent the mediators of 
multiple pathogenic processes. Nicotine, a tertiary amine, 
should by no means be considered an inert molecule. For 
example, it can cause vasoconstriction in specific vascular 
beds but dilatation in others.9,10
Nicotine can increase the heart rate (by 10–15 beats/
min) and the blood pressure (by 5–10 mm Hg) and can 
induce pathogenic changes to the endothelium that are 
associated with the atherosclerotic process.11,12
Although smoking is implicated in the development 
of cancer, nicotine itself is not carcinogenic, unless it 
undergoes nitrosation to form nitrosamines (a process 
known to occur during tobacco curing and combustion).9
The Damage Potential of Various Nicotine 
Delivery Systems
Cigarettes
The danger of the modern cigarette is potentially inc-
reased because it is highly sophisticated and addictive. 
The cigarette is the most dangerous form of nicotine 
delivery device.13 Although cigarette composition varies 
between countries, 8 to 10 over time the mortality out-
come per pack year has varied little.14 The development 
of the modern cigarette is well-chronicled by industry 
documents.15,16 Suggesting that its addictive properties 
may have been enhanced over recent decades. Further-
more the widespread use of ventilated filters facilitates 
compensatory smoking.17
Cigars and Pipes
Cigar causes lower mortality ratios for chronic obstructive 
lung disease, coronary heart disease, and lung cancer 
than do cigarette smokers. The lower risks associated 
with primary cigar smoking probably reflect the fact that 
many such smokers are satisfied by buccally absorbed 
nicotine and do not develop the habit of inhaling the 
smoke into the lungs. The risk of laryngeal cancer are 
just half, whereas those of oral and esophageal cancer 
are similar. An inhaling smoker of five cigars daily 
experiences the same lung cancer risk as a one pack per 
day cigarette smoker.18 Less information is available 
for pipe smokers, who often are classified with cigar 
smokers and may have mixed habits,19 but the mortality 
outcomes are substantially less than those associated 
with cigarettes.20-22 
Smokeless Tobacco
Smokeless tobacco use is associated with increased 
risk of cancers of the oropharyngeal area.23 A review 
of US studies concluded that snuff use increases risk of 
oropharyngeal cancers.24 However, risks vary greatly 
according to the dose and form of tobacco mix used. 
Another study reported increased risk of oral cancer and 
high relative risks for cancer of the buccal mucosa and 
gums among snuff users.25
Use of Swedish snus has not been associated with 
increased risk of oropharyngeal cancer.26 The reason for 
the same may be related to lower levels of tobacco specific 
nitrosamines in Swedish snus compared to many US 
smokeless tobacco products.
SYMPTOMS OF NICOTINE WITHDRAWAL
Much of the inability to quit tobacco is due to problems of 
withdrawal symptoms and cravings. These withdrawal 
symptoms particularly irritability, restlessness, feeling 
miserable, impaired concentration, and increased 
appetite begin within hours of the last cigarette and are 
at maximal intensity for the first week. 
SOCIAL AND BEHAVIORAL ASPECTS
Social influences greatly influence addiction patterns. 
These can be used to discourage smoking—as, e.g., 
with the cultural disapproval of smoking in some 
Garima Bhambhani et al 
92
communities, non-use of tobacco in professional 
groups, or the effects of smoke-free policies in 
workplaces.
The primary reinforcing properties of nicotine 
ultimately sustain smoking behavior. For a 20 a day 
smoker, “puff by puff” delivery of nicotine to the brain is 
linked to the sight of the packet, the smell of the smoke, 
and the scratch in the throat some 70,000 times each year. 
This no doubt accounts for smokers’ widespread concern 
that if they stopped smoking they would not know what 
to do with their hands, and for the ability of smoking 
related cues to evoke strong cravings. 
Other factors encourage smoking, such as being 
married to a smoker or being part of social networks in 
socially disadvantaged groups, among whom prevalence 
is so high as to constitute a norm.
REGULATION OF NICOTINE INTAKE
Within individuals, nicotine preferences emerge early 
in the smoking career and seem to be stable over time. 
Smokers show a strong tendency to regulate their nicotine 
intakes from cigarettes within quite narrow limits. 
They avoid intakes that are either too low (provoking 
withdrawal) or too high (leading to unpleasant effects 
of nicotine overdose). Compensatory puffing and 
inhalation, operating at a subconscious level, ensure 
that nicotine intakes are maintained. As nicotine and 
tar delivery in smoke are closely coupled, compensatory 
smoking likewise maintains tar intake and defeats any 
potential health gain from lower tar cigarettes. Similar 
compensatory behavior occurs after cutting down on the 
number of cigarettes smoked each day; hence, this popular 
strategy fails to deliver any meaningful health benefits.
SOCIOECONOMIC STATUS AND NICOTINE 
ADDICTION
It is alarming to note that an emerging phenomenon of 
the utmost has been the increasing association of chronic 
smoking with markers of social disadvantage which can 
partly be attributed to the fact that poorer smokers tend to 
have higher levels of nicotine intake and are substantially 
more dependent on nicotine. 
It is evident that future progress in reducing smoking 
is increasingly going to have to tackle the problems posed 
by poverty.
Cigarette dependence is a chronic relapsing condition 
that for many users entails a struggle to achieve long- 
term abstinence that extends over years or decades. 
Successful interventions need to tackle the interacting 
constellation of factors—personal, family, socioeconomic, 
and pharmacological—that sustain use and can act as 
major barriers to cessation.
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